EHMT2 and acute promyelocytic leukemia: EGCG treatment has been demonstrated to decrease DNMT1 levels, as well as euchromatic histone lysine methyltransferase 2 (G9a), HDAC1/2 and polycomb repressive complex 2 (PRC2) in acute promyelocytic leukemia cells.